Cargando…
In situ Vaccination by Direct Dendritic Cell Inoculation: The Coming of Age of an Old Idea?
For more than 25 years, dendritic cell (DC) based vaccination has flashily held promises to represent a therapeutic approach for cancer treatment. While the vast majority of studies has focused on the use of antigen loaded DC, the intratumoral delivery of unloaded DC aiming at in situ vaccination ha...
Autores principales: | Castiello, Luciano, Aricò, Eleonora, D'Agostino, Giuseppina, Santodonato, Laura, Belardelli, Filippo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773832/ https://www.ncbi.nlm.nih.gov/pubmed/31611878 http://dx.doi.org/10.3389/fimmu.2019.02303 |
Ejemplares similares
-
Chimeric Antigen Receptor Immunotherapy for Solid Tumors: Choosing the Right Ingredients for the Perfect Recipe
por: Castiello, Luciano, et al.
Publicado: (2022) -
Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?
por: Aricò, Eleonora, et al.
Publicado: (2020) -
Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications
por: Aricò, Eleonora, et al.
Publicado: (2019) -
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma
por: Rozera, Carmela, et al.
Publicado: (2015) -
Concomitant detection of IFNα signature and activated monocyte/dendritic cell precursors in the peripheral blood of IFNα-treated subjects at early times after repeated local cytokine treatments
por: Aricò, Eleonora, et al.
Publicado: (2011)